UAS regulatory sequences drive expression of an inverted repeat.
The expression of MarfJF01650 under the control of Scer\GAL4dome-PG14 leads to the blood progenitors in the third instar larva lymph gland to show a decreased mitochondria footprint, with mitochondria displaying fewer, shorter branches and fewer junctions. The lymph gland shows an increase in prohemocyte number in the tertiary lobe, an increase in the number of plasmatocytes in the secondary lobe, and an increase in crystal cells in the secondary and tertiary lobes.
Expression under the control of Scer\GAL4e33C leads to an increase in crystal cells in the primary lobe of the third instar larval lymph gland.
Expressing MarfJF01650 under the control of Scer\GAL4Cg.PA leads to fragmented mitochondria in the third instar larval fat body (as assessed by MitoGFP).
Wild-type flies upon infection with Serratia marcescens display thinning of intestinal epithelium due to cytoplasm extrusion and accompanied by accumulation of megamitochondria, however in flies expressing MarfJF01650 under the control of Scer\GAL4NP3084 (together with tub-Gal80[ts] to limit the time of expression) that do not form megamitochondria the epithelium thinning is still observed.
Expression of MarfJF01650 driven by Scer\GAL4Cg.PA results in fragmented, swollen mitochondria that lose most of their cristae.
Flies expressing MarfJF01650 under the control of Scer\GAL4GMR.PU do not exhibit any discernible eye phenotype, as compared to controls.
Expression of MarfJF01650 under the control of Scer\GAL4Bx-MS1096 does not result in a wing phenotype.
Expression of MarfJF01650 under the control of Scer\GAL4elav.PU has no effect on mitochondrial length in adult neurons. The amount of cell death and cell cycle activation are similar to controls, as are levels of superoxide production.
MarfJF01650, Scer\GAL4e33C has increased cell number | third instar larval stage phenotype, enhanceable by asrij9/asrij9
MarfJF01650, Scer\GAL4dome-PG14 has increased cell number | third instar larval stage phenotype, enhanceable by asrijGD2167, Scer\GAL4dome-PG14
MarfJF01650, Scer\GAL4GMR.PU is an enhancer of visible | adult stage | progressive phenotype of Chchd2S81L.UAS, Scer\GAL4GMR.PU
MarfJF01650, Scer\GAL4dome-PG14 is an enhancer of increased cell number | third instar larval stage phenotype of Scer\GAL4dome-PG14, asrijGD2167
Scer\GAL4e33C/MarfJF01650 is an enhancer of increased cell number | third instar larval stage phenotype of asrij9
MarfJF01650, Scer\GAL4Cg.PA is an enhancer of abnormal size | third instar larval stage phenotype of DhprHMC05508, Scer\GAL4Cg.PA
MarfJF01650, Scer\GAL4GMR.PF is an enhancer of increased cell death phenotype of Scer\GAL4GMR.PF, egrUAS.cIa
MarfJF01650, Scer\GAL4hs.2sev is an enhancer of increased cell death phenotype of Mmus\Gria1Lc.UAS, Scer\GAL4hs.2sev
MarfJF01650, Scer\GAL4elav.PU is a suppressor of abnormal neuroanatomy phenotype of Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU
MarfJF01650, Scer\GAL4elav.PU is a suppressor of abnormal cell death phenotype of Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU
MarfJF01650, Scer\GAL4elav.PU is a suppressor of abnormal cell cycle phenotype of Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU
Scer\GAL4hs.2sev, BacA\p35GMR.PH/MarfJF01650 is a non-suppressor of increased cell death phenotype of Mmus\Gria1Lc.UAS, Scer\GAL4hs.2sev
MarfJF01650, Scer\GAL4dome-PG14 has embryonic/larval crystal cell | third instar larval stage | increased number phenotype, enhanceable by asrijGD2167, Scer\GAL4dome-PG14
MarfJF01650, Scer\GAL4dome-PG14 has embryonic/larval lymph gland | third instar larval stage phenotype, enhanceable by asrijGD2167, Scer\GAL4dome-PG14
MarfJF01650, Scer\GAL4e33C has embryonic/larval crystal cell | third instar larval stage | increased number phenotype, enhanceable by asrij9/asrij9
MarfJF01650, Scer\GAL4e33C has embryonic/larval lymph gland | third instar larval stage phenotype, enhanceable by asrij9/asrij9
MarfJF01650, Scer\GAL4Cg.PA has mitochondrion phenotype, suppressible | partially by MigaUAS.RFP(Unk), Scer\GAL4Cg.PA
MarfJF01650, Scer\GAL4GMR.PU is an enhancer of eye phenotype of Chchd2S81L.UAS, Scer\GAL4GMR.PU
MarfJF01650, Scer\GAL4dome-PG14 is an enhancer of embryonic/larval crystal cell | third instar larval stage | increased number phenotype of Scer\GAL4dome-PG14, asrijGD2167
MarfJF01650, Scer\GAL4dome-PG14 is an enhancer of embryonic/larval lymph gland | third instar larval stage phenotype of Scer\GAL4dome-PG14, asrijGD2167
Scer\GAL4e33C/MarfJF01650 is an enhancer of embryonic/larval lymph gland | third instar larval stage phenotype of asrij9
Scer\GAL4e33C/MarfJF01650 is an enhancer of primary lobe of embryonic/larval lymph gland | third instar larval stage phenotype of asrij9
MarfJF01650, Scer\GAL4Cg.PA is an enhancer of mitochondrion | third instar larval stage phenotype of DhprHMC05508, Scer\GAL4Cg.PA
MarfJF01650, Scer\GAL4Cg.PA is an enhancer of embryonic/larval fat body | third instar larval stage phenotype of DhprHMC05508, Scer\GAL4Cg.PA
MarfJF01650, Scer\GAL4Bx-MS1096 is an enhancer of wing phenotype of Scer\GAL4Bx-MS1096, fogUAS.cRa
MarfJF01650, Scer\GAL4Bx-MS1096 is an enhancer of wing | male limited phenotype of Scer\GAL4Bx-MS1096, fogUAS.cRa
MarfJF01650, Scer\GAL4GMR.PF is an enhancer of eye phenotype of Scer\GAL4GMR.PF, egrUAS.cIa
MarfJF01650, Scer\GAL4hs.2sev is an enhancer of eye phenotype of Mmus\Gria1Lc.UAS, Scer\GAL4hs.2sev
Scer\GAL4e33C/MarfJF01650 is a suppressor | partially of mitochondrion | third instar larval stage phenotype of asrij9
Scer\GAL4e33C/MarfJF01650 is a suppressor | partially of prohemocyte | third instar larval stage phenotype of asrij9
Scer\GAL4e33C/MarfJF01650 is a suppressor | partially of embryonic/larval lymph gland | third instar larval stage phenotype of asrij9
MarfJF01650, Scer\GAL4dome-PG14 is a suppressor of mitochondrion | third instar larval stage phenotype of Scer\GAL4dome-PG14, asrijGD2167
MarfJF01650, Scer\GAL4dome-PG14 is a suppressor of prohemocyte | third instar larval stage phenotype of Scer\GAL4dome-PG14, asrijGD2167
MarfJF01650, Scer\GAL4dome-PG14 is a suppressor of embryonic/larval lymph gland | third instar larval stage phenotype of Scer\GAL4dome-PG14, asrijGD2167
MarfJF01650, Scer\GAL4elav.PU is a suppressor of mitochondrion phenotype of Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU
MarfJF01650, Scer\GAL4elav.PU is a suppressor of adult brain phenotype of Hsap\MAPTR406W.UAS, Scer\GAL4elav.PU
Scer\GAL4hs.2sev, BacA\p35GMR.PH/MarfJF01650 is a non-suppressor of eye phenotype of Mmus\Gria1Lc.UAS, Scer\GAL4hs.2sev
Co-expression of MigaScer\UAS.T:Disc\RFP partially suppresses mitochondrial defects seen in fat body cells in flies with expression of MarfJF01650 driven by Scer\GAL4Cg.PA.
Expression of MarfJF01650 under the control of Scer\GAL4Bx-MS1096, leads to a clear enhancement of the wing phenotype found in flies expressing fogScer\UAS.cRa, with complete penetrance: in males, the wings appear small or stub-like, similar to parental males, and all females show short and abnormal wings, indicating that inhibiting mitochondrial fusion through down-regulation of Marf potentiates fog signalling.
Co-expression of Hsap\UCP2Scer\UAS.cFa and MarfJF01650 under the control of Scer\GAL4GMR.PU does not result in a rough eye phenotype.
The presence of MarfJF01650 strongly enhances the reduced adult eye size phenotype found in Scer\GAL4hs.2sev->Mmus\Gria1Lc.Scer\UAS flies.
A BacA\p35GMR.PH/+ background fails to suppress the adult eye size defect found upon co-expression of Mmus\Gria1Lc.Scer\UAS and MarfJF01650 under the control of Scer\GAL4hs.2sev.
Expression of MarfJF01650 significantly suppresses the increase in mitochondria length seen when Hsap\MAPTR406W.Scer\UAS is expressed under the control of Scer\GAL4elav.PU. The increases in neurotoxicity and cell cycle activation are also significantly rescued.
Expression of MarfJF01650 suppresses the increase in superoxide production seen when Hsap\MAPTR406W.Scer\UAS is expressed under the control of Scer\GAL4elav.PU.